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A B S T R A C T   
Objectives: A multicentre survey was designed to evaluate the impact of COVID-19 outbreak on dental practice 
worldwide, estimate the COVID-19 related symptoms/signs, work attitudes and behaviour and the routine use of 
protective measures and Personal Protective Equipment (PPE). 
Methods: A global survey using a standardized questionnaire with research groups from 36 countries was 
designed. The questionnaire was developed and pretested during April 2020 and contained three domains: 1) 
Personal data; 2) COVID-19 positive rate and symptoms/signs presumably related to the coronavirus; 3) Working 
conditions and PPE adopted after the outbreak. Countries’ data were grouped by the Country Positive Rate (CPR) 
during the survey period and by Gross-National-Income per capita. An ordinal multinomial logistic regression 
model was carried out with COVID-19 self-reported rate referred by dental professionals as dependent variable to 
assess the association with questionnaire items. 
Results: A total of 52,491 questionnaires were returned with a male/female ratio of 0.63. Out of the total re-
spondents, 7,859 dental professionals (15%) reported symptoms/signs compatible with COVID-19. More than 
half of the sample (n = 27,818; 53%) stated to use FFP2/N95 masks, while 21,558 (41.07%) used eye protection. 
In the bivariate analysis, CPR and N95/FFP2 were significantly associated (OR = 1.80 95%CI = 1.60/2.82 and OR 
= 5.20 95%CI = 1.44/18.80, respectively), while Gross-National-Income was not statistically associated with CPR 
(OR = 1.09 95%CI = 0.97/1.60). The same significant associations were observed in the multivariate analysis. 
Conclusions: Oral health service provision has not been significantly affected by COVID-19, although access to 
routine dental care was reduced due to country-specific temporary lockdown periods. While the dental profes-
sion has been identified at high-risk, the reported rates of COVID-19 for dental professionals were not signifi-
cantly different to those reported for the general population in each country. These findings may help to better 
plan oral health care for future pandemic events.   
1. Introduction 
The COVID-19 outbreak worldwide has had severe repercussions on 
individual behaviours and social interaction. Viral transmission occurs 
mainly through inhalation/ingestion/direct mucous contact with saliva 
droplets. Additionally, the virus could stagnate on hands, objects or 
surfaces for a long time and remain infectious [1]. 
Among the many potential sources of transmission and spread of 
SARS-CoV-2, dental services have received high attention [2–4]. Dental 
professionals are at the front line of healthcare, working in the mouth, 
with a potentially increased viral exposure. Indeed, according to the 
USA’s Occupational Safety and Health Administration agency, all dental 
healthcare personnel (dentist, dental hygienist and dental assistant) are 
included at the highest risk category for SARS-CoV-2 exposure [4]. The 
putative risk posed by the dental profession was widely conveyed on 
mainstream media [5]. Whether this assertion is justified and supported 
by worldwide data, is elusive. We, therefore, decided to explore this issue 
through a global multicentre research survey among dental professionals. 
During the first months of the COVID-19 pandemic, with extremely 
high infection rates and relatively high mortality, many national au-
thorities worldwide, including some dental organizations, imposed 
several restrictive measures on the profession. In most countries, dental 
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care was restricted during the COVID-19 outbreak and limited only to 
urgent care. Implementation of effective infection control measures was 
recommended to prevent nosocomial coronavirus infection [6]. Thus, 
the dental profession was forced to change in March-April 2020 to 
accommodate to new regulations and guidelines. By the beginning of the 
pandemic and during lockdown periods, dental treatment has been 
generally suspended or postponed, except for urgent care. The response 
of the dental profession to COVID-19 has not been homogeneous. While 
some countries restricted dental care only to urgencies/emergencies, in 
others, where the pandemic had subsided or even during the phase of 
maximum infection rates, dental clinics and offices had returned/con-
tinued to also provide non-urgent dental care, but figures from global 
data are not available. Moreover, limited knowledge at that time, un-
availability of tests, availability or incorrect use of Personal Protective 
Equipment (PPE) and conflicting protocols may have lowered protection 
among the dental care workforce and patients, potentially increasing the 
infection rate and transmission [7–10]. This paper reports findings from 
the 2020 International Collaborative COVID-19 Disease Study giving, to 
the best of authors’ knowledge, the only updated worldwide observa-
tional epidemiological study on COVID-19 and dental professionals. The 
study describes morbidity due to COVID-19 among dental personnel in 
36 countries/areas from May to August 2020, as well as the approaches 
to protective measures used to reduce the risk of viral infection and 
transmission. 
The aim of this global survey was to evaluate the impact of the 
COVID-19 outbreak among dental professionals in different countries 
worldwide, via an extensive multicentre study. Due to the numerous 
data collected of this global study, this is the first paper of a series of 
epidemiological publications of dental professionals regarding COVID- 
19. The main aims were to estimate the impact of COVID-19 on oral 
health service provisions, the disease rate among dental professionals 
globally, describe self-reported symptoms/signs presumably related to 
COVID-19, and to investigate the adoption of protective measures and 
the PPE used to reduce the risk of viral infection and transmission. 
2. Materials and Methods 
2.1. Study design 
The structured closed cross-sectional survey was developed with a 
modified Delphi method using a standardized questionnaire developed 
and pretested in Italy during April 2020 [9]. Briefly, following the 
Stehr-Green scale, the questionnaire was built up and structured into 
three domains: 1) personal data including age, gender, area of living and 
working, and working status; 2) dental professionals infection rate and 
symptoms/signs presumably related to the COVID-19; 3) working con-
ditions and PPE adopted after the outbreak of the infection (Appendix 
2). A pre-test before the Italian survey was performed with twelve dental 
professionals, reaching a satisfactory Intra-class Correlation Coefficient 
(ICC) value of 0.80 for each item. 
The protocol of the study was previously described and registered in 
the World Pandemic Research Network (WPRN) WPRN-486352 [10]. 
The study follows the CHERRIES guidelines (the checklist is available as 
supplementary file). Thirty-six collaborating research groups around the 
world were contacted by the central management team and all agreed to 
participate. Each research team was instructed on the research protocol, 
the survey design and the participant search strategies by a central 
coordinator (GC). Research teams were formed individually in each 
country and tasks were assigned at their convenience. 
2.2. Participants and study size 
Dental professionals working in each national health system, either 
private or public, including general or specialists were enrolled. Each 
country performed a sample size calculation; the total number of 
working dental professionals was ascertained, and according to the 
previously published protocol, at least a high proportion of participants 
(5-20%) in each country was invited to participate, aiming to reach 
minimum 5% proportion [10]. In order to reach this purpose, each na-
tional team could use the strategies that best suited the context of their 
country. Study participants were reached in each country via adequate 
platforms to avoid duplicate answers, and the invites were sent through 
the national Dental Board systems, official web pages of national Dental 
Boards and/or social media groups/pages. The number of invited dental 
professionals ranged from all personnel registered by the national Dental 
Board to members of the professional social media groups. A mixed 
strategy was used; direct email to individual dental professionals, in-
vitations to participate through national dental associations and other 
related organizations and dissemination on social media (i.e. Facebook), 
so it was not possible to estimate how many invitations had been 
disseminated in many countries. The number of respondents and rele-
vant demographic data for each country is shown in Table 1. 
2.3. Bias 
The platform used to collect data and run the survey in each country 
was set to avoid duplicate answers. The duration of the survey in each 
country was at least one week according to the previously published 
protocol [10] (Table 1). All national research teams sent accurately 
collected and organized data according to the protocol, with the written 
report on country level data. 
Each country/region translated the questionnaire, performed a pilot 
test and semantically adjusted the questions, if necessary. The same core 
questionnaire was mandatorily applied to all participating countries, 
regardless of optional additional questions incorporated by each na-
tional team. The full questionnaire is presented as supplementary ma-
terial (Appendix 2). A description of the survey’s aim along with the link 
to the questionnaire and an online informed consent were provided to 
each participant in accordance with the applicable data protection laws 
of the respective countries. In some countries, the project protocol and 
the consent form were approved by the local Ethics Committee. Each 
participant was defined by a unique identification number based on IP 
address. Participants were allowed to review and correct their answers, 
but if they did not sign the consent, the questionnaire was automatically 
closed. Data collection timeframe was from May to August 2020. All 
data were stored in a repository using a Research Electronic Data Cap-
ture (REDCap) account. 
2.4. Independent variables and data sources 
Data from all the participating countries were stratified in several 
ways:  
- if the dental professionals in the different countries continued to 
work routinely during the lockdown or limited the clinical activity to 
emergencies only;  
- by the country/region (i.e. California not U.S.A. etc.) community 
positive rate (CPR) of COVID-19 during the survey period (Table 1) 
[11]. The CPR were calculated using the Git Hub data [12] and, 
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where internationally available data were not updated, by the na-
tional research teams obtaining data from the official national web 
page reporting COVID-19 statistical recourses in each local language.  
- by Gross National Income (GNI) per capita 2019, Atlas method and 
Purchasing Power Parity (PPP, international dollar) [13]. 
2.5. Outcome variables 
Ordinal multinomial linear regression analysis was run using the 
COVID self-reported rate as dependent variable to evaluate the associ-
ation with questionnaire items. COVID self-reported rate was calculated 
using data derived from the questionnaire, reporting one or more spe-
cific or nonspecific COVID symptoms [14,15]. Clinical manifestations of 
COVID-19 appear after an incubation period of around 5–6 days and 
most frequently include fever, dry cough, tiredness with the possible 
onset of sputum production, headache, haemoptysis, diarrhoea, dysp-
noea, and/or lymphopenia amongst others [16–20]. 
2.6. Statistical Analysis 
Data were exported to an Excel (Microsoft Corp., WA, USA) spread 
sheet and quality-checked to ensure accuracy, sent to the management 
team (GC, MDB, MGC, TGW) and transferred to STATA16™ (Statacorp, 
TX, USA) for statistical analysis. The raw data were added as a supple-
mentary file (Appendix 3). Data analysis was performed centrally. De-
mographic data and the impact of COVID-19 on dental professionals and 
oral health provision were descriptively presented. 
All demographic data were completed without missing data. Missing 
data were present on the outcome variables and complete case analysis 
was selected as the primary analysis with no imputation [21,22]. Ab-
solute and relative frequencies were calculated for each item. Differ-
ences in proportions were evaluated with χ2 test or Fisher exact test if 
one cell had a value of less than five. Multiple testing for post hoc esti-
mation, such as the number of observed frequencies, expected fre-
quencies, percentage, and contribution to the chi-square were run. 
Estimation of a nonparametric test for trend across the areas with 
different prevalence of COVID self-reported rate and questionnaire items 
were also calculated. The effect size was calculated using the Cramer’s 
V, as a measure of the strength of association among the levels of the row 
and column variables. Ordinal multinomial linear regression analysis 
was run to evaluate the association with questionnaire items. 
3. Results 
The map of the countries participating in the survey, the Country 
Positive Rate (CPR) to COVID-19 according to the survey period and 
COVID self-reported positive rate are displayed in Fig. 1. A total of 
52,491 dental professionals from the 36 countries completed the ques-
tionnaires. The total population, survey period (2020), total new cases 
during the survey period, the positive rate, the type of oral health care 
provision, the reported number of dental professionals, the hypothetical 
sample at the 5% level and the number of dental professionals reached in 
each country by continent, country/area is displayed in Table 1. 
3.1. Descriptive data 
In most countries, the dental professionals sex ratio favoured women 
(i.e. in Russia 100% were women), whilst Switzerland had the highest 
ratio for males (1.97). More than 50% of the dental professionals in 
countries such as Argentina, Peru, USA/California, Venezuela, Australia, 
Albania, Belgium, Cyprus, Chile, Germany, Greece, Italy, Lithuania, 
Macedonia, Montenegro, Netherlands, Romania, Spain and Switzerland, 
reported to work as owners of a private practice. Working within a 
National Health System or at Universities or for administrative staff was 
reported highly by Nigerian, Chinese (province of Hubei), Malaysian, 
Singaporean and UK dental professionals. The majority were general 
dental professionals (43.2% versus 23.61% specialists), one third of the 
participants did not enter this item. 
Table 1 shows the impact of the COVID-19 pandemic on the provi-
sion of routine oral health services globally. Only 14 of the 36 countries 
reported to perform routine cares across both private and public sectors 
during the survey period. Thirteen countries reported provision of 
emergency care only. Almost 80% (n = 41,776) of dental professionals 
continued providing some face-to-face clinical activities, many despite 
limited access to appropriate PPE. 
3.2. Self-reported prevalence of COVID-19 in dental professionals 
Overall, 15% of respondents (n = 7,859) reported symptoms/signs 
pertaining to COVID-19. This was higher in the Americas, in particular, 
Perú and El Salvador where more than two thirds of the respondents 
reported experiencing at least one symptom assumed to be from COVID- 
19. Of those who reported signs of having COVID-19, more than 90% 
reported to have worked clinically during the outbreak, while the 
remainder had only community level exposure, many unable to work or 
working from home offering remote dental advice (Teledentistry) and 
triage services. 
Participating dental professionals were grouped by the positive 
rates registered at the country level (CPR) and by the COVID self- 
reported rate (Table 2). The COVID self-reported rate ranged be-
tween 0% in some Balkan Countries and Nigeria to over 10% in Russia 
(14.68%) and Pakistan (17.34%). At country level, the community 
rates of COVID-19 were usually higher than those reported by the 
dental participants, except for China, Malaysia, Netherlands, Pakistan, 
Russia, Saudi Arabia and Tunisia, where the results were higher for 
dental professionals than the CPR. 
3.3. Protecting measures for patients and dental professionals 
The precautionary measures adopted by dental professionals who 
continued to work after the COVID-19 outbreak are displayed in Table 3. 
More than half of the dental professionals (n = 27,818; 53%) reported 
the use of FFP2/N95, while 41.07% (n = 21,558) declared the use of eye 
protection equipment. The percentage of dental professionals who re-
ported routine use of protective mask (FFP2/N95) was notably high in 
South American countries with low GNI (Brazil, Peru and Colombia with 
100%). In most countries, more than half of the dental professionals 
reduced the number of patient appointments to reduce crowding in the 
waiting room, with the highest percentage in countries with the highest 
GNI, i.e. Germany (93.84%). The patients’ health status and body tem-
perature were checked by 57.6% of the respondents, with the highest 
prevalence in countries with the highest GNI (Australia 99.84% and 
Germany 91.05%). The use of mouthrinses intended to reduce SARS- 
CoV-2 salivary load was highly variable, but some trends between 
countries with different GNI were observed regarding the use of alcohol- 
containing mouthrinses and essential oils or cetylpyridinium chloride (p 
= 0.01 and p < 0.01, respectively) (data not tabulated). 
When COVID self-reported rate among dental professionals was used 
as the dependent variable for an ordinal multinomial regression model 
(Table 4), CPR and N95/FFP2 were statistically significantly associated (β 
= 1.07 and β = -1.46, respectively both p < 0.01). Also, GNI was statis-
tically associated to the test-positive rate among dental professionals ( β =
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Table 1 
Participating Countries survey Information.  
Country Population size 













Responders % Positive/ 
rate COVID- 
19 test in 
population 
Oral health service provision/restrictions nationally(survey 
period)         
Private Public (Hospitals, etc.)   
Start End     Urgent Routine None Urgent Routine None 
Africa              
Egypt 102,334,404 16.07 31.07 9,827 19,111 925 24.41  Yes  Yes, 
only   
Nigeria 24,206,644 11.06 29.07 28,340 4,000 438 2.10  Yes  Yes, 
only   
Tunisia 11,818,619 08.07 25.07 237 4,500 871 1.51  Yes   Yes  
America              
Argentina 44,938,712 16.06 31.07 147,419 54,000 1,422 34.43 Yes, 
only   
Yes, 
only   
Brazil 212,559,417 27.07 31.07 215,589 645,889 1,837 30.15 Yes, 
only   
Yes, 
only   
Chile 19,116,201 20.07 01.08 26,821 21,541 2,307 10.98 Yes, 
only   
Yes, 
only   
Colombia 50,882,891 19.06 24.07 212,382 36,000 5,375 26.60 Yes, 
only   
Yes, 
only   
El Salvador 6,486,205 12.07 21.07 3,065 2,100 543 12.40 Yes, 
only     
None 
Peru 32,971,854 25.07 31.07 38,744 30,000 1,759 23.55  Yes    None 
USAa 39,512,223 05.06 31.07 370,687 28,800 562 7.00 Yes, 
only   
Yes, 
only   
Venezuela 28,435,940 18.07 28.07 5,134 12,000 638 5.46  Yes    None 
Asia and 
Oceania              
Chinab 58,500,000 13.07 28.07 0 7,750 1,116 0  Yes   Yes  
India 1,380,004,385 11.07 25.07 543,059 277,303 3,265 10.92 Yes, 
only   
Yes, 
only   
Malaysia 32,365,999 01.07 15.07 92 11,108 2,904 0.09  Yes  Yes, 
only   
Pakistanc 220,892,340 16.07 30.07 21,633 2,226 425 16.27  Yes  Yes, 
only   
Saudi 
Arabia 
34,813,871 02.07 30.07 81,767 16,752 857 5.17 Yes, 
only   
Yes, 
only   
Singapore 5,850,342 15.07 02.08 6,229 2,390 355 7.30  Yes   Yes  
Australia 25,667,000 13.07 31.07 6,750 16,861 815 0.69  Yes   Yes  
Europe              
Albania 2,877,797 16.07 31.07 2,850 2,776 206 39.1 Yes, 
only   
Yes, 
only   
Belgium 115,89,623 30.07 04.08 3,273 10,080 782 2.68       
Bosnia 3,280,819 29.06 12.07 2,863 2,233 213 17.0  Yes   Yes  
Cyprus 1,207,359 16.07 31.07 62 1,017 176 0.49  Yes   Yes  
Georgia 3,989,167 10.07 31.07 192 3,050 317 1.48  Yes   Yes  
Greece 10,423,054 16.07 31.07 518 10,200 46 0.44       
Germany 83,783,942 04.06 16.06 4,469 70,740 3,542 0.70  Yes   Yes  
Italy 60461826 04.05 18.05 15,293 49,413 8,284 2.90 Yes, 
only   
Yes, 
only   
Lithuania 2,722,289 12.07 24.07 99 3,800 204 0.46  Yes   Yes  
Macedonia 2,083,374 16.07 31.07 2,232 2,800 24 10.4 Yes, 
only   
Yes, 
only   
Montenegro 628,066 16.07 31.07 1,184 591 110 14.84  Yes   Yes  
Netherlands 17,134,872 08.07 06.08 5,724 8,600 372 1.00  Yes   Yes  
Romania 19,237,691 16.07 31.07 16,006 16,442 1,051 4.72  Yes   Yes  
Russia 145,934,462 09.06 07.26 339,047 50,000 1,011 12.55 Yes, 
only   
Yes, 
only   
Serbia 8,737,371 16.07 31.07 6,230 4,677 1,460 4.06  Yes   Yes  
Spain 46,754,778 29.05 11.06 4,374 38,000 2,318 0.80 Yes, 
only   
Yes, 
only   
Switzerland 8,654,622 02.07 15.07 1,300 5,777 1,324 1.26  Yes   Yes  
UK 67,886,011 01.06 04.07 31,751 39,500 4,637 1.09 Until 
08.06 
Yes  Yes, 
only   
TOTAL      52,491        
aUSA/California; bChina/Hubei; cPakistan/Lahore; ^https://www.worldometers.info/coronavirus 
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0.72 p = 0.03). The face-to-face clinical activity and Private Practice Rate 
(PPr) (<25%) were not statistically associated to the dependent variable. 
4. Discussion 
This is the first global population-based study, to the authors’ 
knowledge, that describes the effect of COVID-19 on the dental profes-
sion, describing self-reported COVID-19 infection and presumably 
related symptoms/signs suffered, exploring work attitudes and behav-
iour, and investigating the routine use of protective measures and PPE. 
The questionnaire used also included other aspects such as COVID- 
related risk awareness and perception; however, the focus of this proj-
ect was centred on the dissemination of the infection among dental 
professionals and the implemented protection measures for dental pro-
fessionals and patients. The survey included more than 50,000 partici-
pants across 36 countries. Findings showed that living in countries with 
high COVID-19 positive rates increased the probability that the dental 
professionals became infected, although these higher rates could be 
related to infection acquired within the community, as well as at work. 
In terms of protective measures, the use of N95/FFP2 masks significantly 
reduced the chances of the dental professionals reporting symptoms/ 
signs related to the disease, while the other PPEs seem less relevant for 
SARS-CoV-2 protection. Overall, the probability of dental professionals 
becoming infected was associated to the Gross National Income (GNI) of 
the countries where they work. 
The present study offers a global picture of the dental profession and 
COVID-19, even if the large number of respondents cannot be 
considered representative of the entire world population of dental pro-
fessionals; nonetheless, these findings can provide a measurement 
framework and methods for countries and global stakeholders to better 
plan health service provision. 
Although our study provided relevant information on the effect of 
COVID-19 on the dental profession, caution is necessary when inter-
preting the results due to some limitations. First of all, the obvious 
limitation could be choosing COVID self-reported positive rate as 
dependent variable as representative of the impact of the disease in the 
field. In most countries, testing was not available in the earlier stages of 
the pandemic. Moreover, any person who presented any of the symp-
toms related to COVID were asked to isolate. These people were, then, 
certainly impacted by the disease, even if they did not have an official 
positive testing. In this case, the number of professionals who had 
symptoms might be higher than the true prevalence of COVID. Also, 
there is need to highlight the possibility of false negative test results and 
the necessity to measure clinical sensitivity and specificity of each test 
according to real-life situations (symptoms, contacts etc) [23]. Further 
research would be needed to address other outcome data collected 
during this survey, such as tested “positive for COVID", and "hospitalized 
for COVID ". On the other hand, there is possibility that the lack of access 
to testing in low-income countries, may have led to an over-estimation 
of infection due to reliance on untested symptoms. 
Secondly, the time periods for collection of the survey data and in-
dependent reports of dental professional infection rates do not coincide 
since survey was carried out from May to August 2020. The dental 
professionals reported infection rates from the beginning of the 
Fig. 1. COVID-19 positive rates by countries. In blue colour, is reported the COVID-19 positive rate of the population (%) at the time point when the survey was 
conducted, while in red the cumulative COVID-19 positive rate (%) among dental professionals since the beginning of the pandemic. 
aUSA/California; bChina/Hubei; cPakistan/Lahore; https://www.worldometers.info/coronavirus 
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pandemic. However, this does not reduce the relevance of the results, 
since these data were only used to categorize countries and as a metric 
for comparing countries. In addition, these data provide useful infor-
mation on how adequately countries were testing, also in relation to the 
size of the outbreak and thus facilitating the understanding of how 
widespread the virus was, in conjunction with confirmed case data [24]. 
According to World Health Organization (WHO) criteria, a positive 
testing rate of less than 5% is a reliable indicator that the epidemic is 
under control [24]. 
Although these data do not seem to support all the recommended 
enhanced protective measures, except for higher-rated masks, the results 
must be interpreted cautiously, nonetheless. The use of higher-rated 
masks, in itself, may be an indicator of higher levels of protection 
overall. This survey is based on self-reported information in a large 
sample of dental professionals from 36 countries. Importantly, the 
design of this research does not allow inferences to be drawn about cause 
and effect, therefore, conclusions must be carefully drawn. It is possible 
that at the individual level, the use of N95/FFP2 masks alone is not a 
sufficient protection against SARS-CoV-2 infection. It might be specu-
lated that dental professionals wearing N95 masks at work are also more 
likely to wear them when they are in normal life settings, reducing the 
risk of community transmission. However, such appealing hypothesis 
cannot be verified from the present data. 
The pandemic of COVID-19 has affected the entire world, with over 
150 million cases and more than 3.2 million deaths by May 2021, 
worldwide [25], and an increasing infection and death rate in devel-
oping countries. The dental profession has not had universal guidelines 
on how to manage the virus, despite being perceived as having 
extremely high risk for exposure among all professions [2–4]. However, 
data from similar studies in Europe and USA showed that the prevalence 
and the positivity rates among dental professionals/dental hygienists 
was low, suggesting that current infection control recommendations 
against COVID-19 could be appropriate [8,9,25,26]. Similarly, our 
findings follow the same trend for most countries, where infectivity rate 
during the performance of the survey could be retrieved (Tables 2 and 
3). This trend could be at least partially explained by the preventive 
measures frequently implemented by dental professionals all over the 
world, that protect the dentist whilst treating symptomatic patients, 
reducing the risk of infection [27,28]. 
High variability could be observed among countries, but in general, 
dental professionals from countries with higher GNI reported lower 
infection rates, potentially because they were less well protected in lower 
Table 2 
Dentists positive rate to COVID-19 and work condition in the participating dentists.  
Country Dentists positive 
rate 
Positive rate COVID-19 
% 








%¡  N (%)  N (%) N (%) N (%) N (%) 
Pakistanc 17.83 16.27 151 (36.39) 0.40 149 (36.43) 260 (63.57) 98 (24.62) 118 (29.65) 
Russia 14.68 12.55 118 (11.67) 0.00 443 (43.81) 552 (34.59) 368 (36.44) 475 (47.03) 
Saudi Arabia 7.84 5.17 257 (30.09) 0.86 210 (24.59) 628 (73.54) 47 (5.52) 383 (45.06) 
Colombia 6.46 26.60 721 (13.41) 0.38 4327 
(100.00) 
0 (0.00) 126 (2.34) 1002 (18.64) 
Brazil^ 5.02 30.15 188 (10.22) 0.25 1161 (63.18) 664 (36.13) 87 (4.73) 1057 (57.54) 
Tunisia 4.13 1.51 198 (22.73) 0.52 494 (64.98) 305 (35.02) 15 (1.73) 351 (40.53) 
Spain 3.19 4.06 291 (12.55) 0.53 2073 (89.43) 245 (10.57) 18 (0.78) 916 (39.52) 
Peru 3.19 23.55 1721 (97.84) 0.60 1358 
(77.22)◦
720 (40.93) 42 (2.39) 1187 (67.48) 
Egypt^ 3.09 24.41 191 (21.08) 1.31 361 (39.99) 545 (60.15) 146 (15.79) 416 (44.97) 
Argentina 2.41 34.43 130 (9.20) 0.30 1166 (82.51) 247 (17.48) 20 (1.42) 557 (39.42) 
Belgium 2.35 2.68 77 (9.51) 0.73 661 (93.95) 47 (6.05) 280 (35.90) 366 (46.92) 
Chile 2.12 10.98 38 (1.65) 0.49 1592 (69.04) 747 (32.93) 96 (5.16) 1047 (56.26) 
Netherlands 1.90 1.00 65 (17.91) 0.47 368 (100.00) – 253 (69.70) 109 (30.03) 
Bosnia 1.88 17.0 52 (24.41) 0.43 123 (57.75) 90 (42.25) 13 (6.10) 85 (39.91) 
India 1.81 10.92 430 (13.97) 0.86 3302 
(100.00) 
0 (0.00) 24 (0.74) 3240 (99.26) 
El Salvador 1.47 12.40 235 (43.26) 0.50 265 (48.36) 278 (51.19) 20 (3.68) 191 (35.17) 
Georgia^ 1.26 1.48 7 (2.20) 0.38 242 (76.48) 75 (23.66) 31 (9.80) 71 (22.40) 
Italy 1.12 2.90 1346 (16.25) 0.66 7211 (87.05) 1073 
(22.95) 
171 (2.06) 4075 (49.19) 
UKÅ 1.08 1.09 672 (14.49) 0.85 893 (19.26) 3738 
(80.74) 
2121 (45.74) 1102 (23.77) 
Switzerland 0.91 1.26 35 (2.65) 1.97 1288 (97.32) 36 (2.72) 100 (7.58) 296 (22.44) 
USAa 0.89 7.00 10 (1.78) 0.63 467 (83.10)◦ 95 (16.90) 226 (40.14) 222 (39.43) 
Singapore 0.84 7.30 121 (34.03) 0.41 101 (28.44) 254 (71.56) 316 (89.01) 14 (3.94) 
Romania 0.76 4.72 47 (4.47) 0.26 736 (70.03) 315 (29.97) 0 (0.00) 575 (54.71) 
Chinab 0.72 0.00 12 (1.08) 0.55 476 (42.69) 639 (57.31) 40 (3.59) 228 (20.45) 
Germany 0.69 0.70 77 (2.95) 1.43 2619 (99.28) 37 (0.72) 170 (6.84) 2140 (86.15) 
Australia 0.61 0.69 115 (14.11) 0.63 674 (82.85) 140 (17.15) 78 (11.32) 391 (56.75) 
Lithuania 0.49 0.46 13 (6.40) 0.13 138 (67.98) 25 (12.31) 4 (1.97) 42 (20.69) 
Malaysia 0.39 0.09 223 (7.67) 0.13 134 (4.62) 2770 
(95.38) 
2161 (86.47) 226 (9.04) 
Albania 0.00 39.14 5 (3.29) 0.52 128 (84.21) 24 (15.79) 6 (3.95) 23 (15.13) 
Montenegro 0.00 14.84 1 (1.91) 1.11 104 (94.55) 6 (5.41) 18 (16.36) 42 (38.18) 
Macedonia 0.00 10.4 0 (0.00) 0.60 22 (91.67) 2 (8.33) 1 (4.17) 6 (25.00) 
Venezuela^ 0.00 5.46 132 (20.69) 0.26 614 (96.23) 144 (3.77) 17 (2.65) 503 (78.60) 
Serbia 0.00 4.06 175 (11.99) 0.35 1019 (69.80) 441 (30.20) 156 (10.68) 697 (47.74) 
Nigeria 0.00 2.10 0 (0.00) 1.62 98 (23.62) 317 (76.39) 81 (18.54) 164 (37.53) 
Cyprus^ 0.00 0.49 4 (2.27) 0.71 165 (93.75) 170 (96.59) 7 (3.98) 78 (44.32) 
Greece 0.00 0.44 1 (2.17) 0.80 40 (86.96) 6 (13.04) 8 (17.77) 19 (42.22) 
p-value   <0.01 <0.01 <0.01 <0.01 <0.01 <0.01 
aUSA/California; bChina/Hubei; cPakistan/Lahore; ^data calculated by the authors, ◦private, no differentiated; 
*In these Countries other dental personnel participate to the survey; their replies are not reported in this table; ¡Positive/Hospitalized, ÅIn UK the survey involved only 
dentists working in primary care 
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Table 3 
Precautionary measures taken by dentists who continued to provide face to face clinical care after the outbreak of COVID-19. Countries were ranked by the COVID-19 
positive rate by country. In Fig. 2 the COVID-19 positive rate by country and Dentists positive rates are reported.      























range n (%) n (%) n (%) n (%) n (%) n (%) n (%) n (%) n (%) 
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(63.48) 
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(65.53) 
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652 (87.87) 665 (89.62) 725 
(97.71) 
363 (48.92) 742 (100.00) 284 
(38.27) 
76 (10.24) 






1241 (78.10) 725 (45.63) 1086 
(68.34) 
573 (36.06) 1455 (91.57) 1291 
(81.25) 
280 (17.62) 






196 (72.86) 214 (79.5) 175 
(65.06) 
88 (32.71) 230 (85.50) 230 
(85.50) 
117 (43.49) 






66 (38.82) 74 (43.53) 59 
(34.71) 
11 (6.47) 74 (43.53) 57 (33.53) 37 (21.76) 






25 (54.35) 19 (41.30) 16 
(34.78) 
3 (6.52) 22 (47.83) 14 (30.43) 11 (23.91) 










808 (10.74) 2552 (33.93) 6562 
(87.25) 
940 (12.50) 
Lithuania 10,000 / 
<20,000 
71 (34.80) – 14 (19.72) 19 (26.76) 11 
(15.49) 
1 (1.41) 176 (86.70) 100 
(49.26) 
160 (78.82) 



























561 (59.30) 620 (65.54) 335 
(35.41) 











325 (70.96) 337 (73.58) 275 
(60.04) 
105 (22.93) 196 (42.79) 369 
(80.57) 
231 (50.44) 






808 (88.02) 758 (82.57) 376 
(40.96) 
545 (59.37) 870 (94.77) 805 
(87.69) 
231 (25.16) 




448 (62.40) 631 (87.88) 525 
(73.12) 
152 (21.17) 243 (33.84) 191 
(26.60) 
86 (11.98) 




567 (77.46) 573 (78.28) 523 
(71.45) 
116 (15.85) 429 (58.61) 570 
(77.87) 
106 (14.48) 








2460 (98.01) 175 (6.97) 2319 
(92.39) 
841 (33.51) 




263 (73.06) __ 277 
(76.94) 
31 (8.61) 353 (94.89) 59 (16.39) 27 (7.50) 




141 (44.76) 311 (98.73) 275 
(87.30) 




Switzerland >35,000 1083 (87.13) 13 (1.05) 1154 (92.84) 57 (4.59) 
(continued on next page) 
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GNI countries; however, it could also be a reflection on testing protocols 
in high income countries which may have necessitated that healthcare 
workers be tested disproportionately more than the general population. 
In a recent survey among other health professions in the USA, the ma-
jority of responders reported to have access to PPEs [27,29], but the 
situation is different in countries with lower GNI, which may lead to 
higher infection rates. In eight of the surveyed countries, the dental 
professionals’ COVID self-reported rate was higher than that of the 
general population (Pakistan, Russia, Saudi Arabia, Tunisia, Netherlands, 
Lithuania, Malaysia and China). 
When dental professionals continued practicing in countries with 
higher positive rates, our data showed that this also was associated with a 
higher COVID self-reported rate than those working in countries with 
lower rates (Table 4). The results also showed a trend for a higher rate of 
COVID self-reported infection among dental professionals working in 
public rather than private practice. It is reasonable to speculate that in 
hospitals and primary public care centres more people congregate at the 
same time, reducing time to ventilate rooms between patients, increasing 
the risk of virus transmission. It is also possible that, in such places, there 
are higher odds of COVID-19-positive people gathering, among patients, 
institutional staff and accompanying persons. It has been shown that 
other health professionals working in health centres are at a higher risk of 
acquiring the SARS-CoV-2 due to direct contact with positive patients, 
long working hours, lack of preparation or limited access to PPE [7,27, 
29]. This higher risk may be also true for community contacts when 
infection rates are high in the country. 
Although droplets of contaminated secretions and direct contact were 
initially regarded as the main routes for SARS-CoV-2 infection [30], 
aerosol-generating procedures (AGPs) in contaminated environments is 
an indisputable route, in addition to exhalation, speaking, sneezing or 
coughing [3,4,31]. At the present time, nosocomial infection of 
SARS-CoV-2 through the airborne route has not been reported [32]. The 
ordinal multinomial logistic regression showed that only the use of 
N95/FFP2 masks significantly reduced the probability of reporting 
signs/symptoms of COVID-19. Information was not collected to explain, 
when N95/FFP2 masks were not used, the reason for this action; it is 
therefore impossible to know if N95/FFP2 masks were not available to 
dental professionals or if their non-use was due to cost or because they 
were not considered more effective than surgical masks. In other words, 
the use of high-quality masks appears to be the most effective measure to 
avoid infection by SARS-CoV-2. From the HIV/AIDS onset and the 
increased awareness of hepatitis B and C in the 1990’s, the dental pro-
fession adopted strict infection control measures. Indeed, the Center of 
Disease Control (CDC) released guidelines for infection control starting to 
the assumption that every patient in a dental office could be infected with 
HIV or Hepatitis B viruses [33]. These guidelines were later updated, 
based on new evidence, but the philosophy was not altered [34]. This 
may explain the low infection rate among dental professionals, despite 
the aerosol generation and the close proximity to potentially infected 
patients. Dental professionals have a “culture” of infection control. When 
transmission rates of the pandemic are in the respective region high, 
dental professionals should act following a similar behaviour as they did 
in those days for HIV, considering every patient as COVID‑19 positive. 
However, when transmission is low or the pandemic is alleviated, these 
measures will cause waste of resources, contradict sustainability, and add 
burdens to countries where resources are limited. Using higher levels of 
protection should be dependent on community transmission levels of 
COVID-19. The facilities and personnel must undergo an even stricter 
infection control protocol, reduce AGPs, space appointment times, 
establish correct ventilation and train dental and other associated health 
workers [35,36]. Thus, the extra recommendations raised after the 
COVID-19 outbreak were rapidly adopted for most dental professionals 
that continued treating patients, either restricting it to dental urgencie-
s/emergencies or those having elective care [34,35]. Public health or-
ganizations rapidly released enhanced infection prevention and control 
recommendations with specific PPEs, based on the knowledge of 
SARS-CoV-2 at the time. Thus, dental AGPs must be performed wearing 
surgical masks, basic clinical PPE and eye protection. For those care 
providers with no access to high-standard N95/FFP2 masks and when 
performing AGPs, the guidelines strongly suggest using a high-level 
surgical mask along with a face shield over it simultaneously [35,37, 
38]. Handling of equipment is also important, as bacterial contamination 
of masks during manipulation has been recently reported in the AGP 
dental settings [38,39]. Changing the mask after treating a patient fol-
lowed by hand disinfection has been recommended [40]. It is recom-
mended that the current international and national guidelines are 
maintained until evidence dictates otherwise or when the pandemic is 
alleviated. 
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1055 (24.74) 1553 (36.42) 262 (6.14) 120 (2.81) 




387 (83.77) 451 (97.62) 155 
(33.55) 
58 (12.55) 84 (18.18) 48 (10.39) 106 (22.94) 
p-value <0.01  <0.01 <0.01 <0.01 <0.01 <0.01 <0.01 <0.01 <0.01 
aUSA/California; bChina/Hubei; cPakistan/Lahore; *safety glasses or visor; **Reserve for aerosol generating procedures; § Water-repellent gown or disposable sterile 
microfiber gown; ◦ Rotating instrument; 
Table 4 
Ordinal multinomial regression analysis using dentists’ test-positive as depen-
dent variable. For the multivariate analysis the forward stepwise method was 
used.   
Dentists positive rate 
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PPr=Private Practice rate 
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